FDA oversight of laboratory-developed tests where are we now?

Research output: Contribution to journalEditorial

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)746-748
Number of pages3
JournalArchives of Pathology and Laboratory Medicine
Volume141
Issue number6
DOIs
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

FDA oversight of laboratory-developed tests where are we now? / Gatter, Ken.

In: Archives of Pathology and Laboratory Medicine, Vol. 141, No. 6, 01.06.2017, p. 746-748.

Research output: Contribution to journalEditorial

@article{09f747e5a8374b6ba278dd62a62f8599,
title = "FDA oversight of laboratory-developed tests where are we now?",
author = "Ken Gatter",
year = "2017",
month = "6",
day = "1",
doi = "10.5858/arpa.2017-0053-ED",
language = "English (US)",
volume = "141",
pages = "746--748",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "6",

}

TY - JOUR

T1 - FDA oversight of laboratory-developed tests where are we now?

AU - Gatter, Ken

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85020165292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020165292&partnerID=8YFLogxK

U2 - 10.5858/arpa.2017-0053-ED

DO - 10.5858/arpa.2017-0053-ED

M3 - Editorial

C2 - 28557601

AN - SCOPUS:85020165292

VL - 141

SP - 746

EP - 748

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 6

ER -